MORGANTOWN — The West Virginia Clinical and Translational Science Institute has successfully competed renewal for funding from the National Institutes of Health with a five-year $20 million grant to improve health outcomes in West Virginia.
This grant provides five more years of funding, extending WVCTSI’s 2012 Institutional Development Award for Clinical and Translational Research through 2022.
“This funding will enable WVCTSI to reach a new level of statewide programming, supporting West Virginia investigators in academic medical centers and community clinics to find real solutions that will lead to better health for West Virginians,” said Sally Hodder, M.D., WVCTSI director and principal investigator.
With this new grant, WVCTSI will continue to offer funding and services to accelerate the creation and translation of new knowledge to impact health issues in rural communities. Additionally, WVCTSI has planned new programs and support, particularly for early career researchers starting their career in West Virginia…